CREB3 蛋白家族：心血管代谢疾病治疗的有潜力靶点。
CREB3 protein family: the promising therapeutic targets for cardiovascular and metabolic diseases.
机构信息
Department of Geriatrics, Hubei Key Laboratory of Metabolic and Chronic Diseases, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Department of Ultrasound, Clinical Research Center for Medical Imaging in Hubei Province, Hubei Province Key Laboratory of Molecular Imaging, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
出版信息
Cell Biol Toxicol. 2024 Nov 25;40(1):103. doi: 10.1007/s10565-024-09939-5.
Significant advancements in cardiovascular and metabolic disease research have been made with the CREB3 protein family. Studies have revealed that members of this family are crucial in the development of these diseases, contributing to the regulation of lipid metabolism, inflammation, and vascular function. These studies provide useful information for future therapeutic strategies in cardiovascular and metabolic diseases.
CREB3 蛋白家族在心血管和代谢疾病研究方面取得了重大进展。研究表明，该家族成员在这些疾病的发展中起着至关重要的作用，有助于调节脂代谢、炎症和血管功能。这些研究为心血管和代谢疾病的未来治疗策略提供了有用的信息。
Zotero 插件